Samsca Post-marketing General Drug Use-results Survey in Patients with Hyponatremia in SIADH

Otsuka

Status: Enrolling

Conditions: Antidiuretic Hormone, Inappropriate Secretion

Treatments: Drug: Tolvaptan (SAMSCA)

Study type: Observational

Funder types: Industry

Identifiers

NCT04790175

156-101-00348

Details and patient eligibility

About

The purpose of this study is to confirm the safety of tolvaptan in patients with hyponatremia in syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Japan

Enrollment: 300 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with a definite diagnosis of SIADH in reference to "Diagnostic and Treatment Manual of the Hypersecretion of Vasopressin (SIADH), Revised in 2018"

Exclusion criteria